Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses

• Xue Li,

  Affiliation Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China

  ⨯
• Vicki C. Tse,

  Affiliation Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China

  ⨯
• Wallis C. Y. Lau,

  Affiliation Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China

  ⨯
• Bernard M. Y. Cheung,

  Affiliation Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

  ⨯
• Gregory Y. H. Lip,

  Affiliation University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom

  ⨯
• Ian C. K. Wong,

  Affiliations Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China, Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom

  ⨯
• Esther W. Chan

  * E-mail: ewchan@hku.hk

  Affiliation Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China

  ⨯